A Window of Opportunity Trial of Intratumoral Injection of Copaxone® in Patients With Percutaneously Accessible Tumors
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Basal Cell Carcinoma
- Cutaneous Squamous Cell Carcinoma
- Squamous Cell Carcinoma
- Type
- Interventional
- Phase
- Phase 1
- Design
- Allocation: N/AIntervention Model: Single Group AssignmentIntervention Model Description: Single arm, open-label, preoperative, window of opportunity trial.Masking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT03982212
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Joaquina Baranda, MD The University of Kansas Cancer Center
Get Well Soon